Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

When news of the efficacy of the Covid-19 vaccine was first shared, the medical community was astounded not only by the vaccine’s ability to protect people from infection but also by the speed at ...

AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully ...

Senior Manufacturing Science Associate Diane Morgan performs an analysis of plasmid DNA at Vernal Biosciences in Colchester on Tuesday, Aug. 12. Photo by Glenn Russell/VTDigger U.S. Health and Human ...

Meeting the unmet need for a vaccine is the top priority for researchers studying Lyme disease, which infects about 476,000 people in the U.S. each year and can come with severe complications such as ...

The Food and Drug Administration’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory processes. The first sign of trouble was the ...

In fact, the pared-down U.S. vaccine schedule now aims to protect children against fewer diseases than all but one of the 20 ...

Until May, the Duke Consortia for HIV/AIDS Vaccine Development (CHAVD) had conducted its groundbreaking research with federal funding. Then the National Institutes of Health terminated the program, ...